The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline. The test, ...
The FDA cleared the Elecsys Phospho-Tau (217P) Plasma blood test, which Roche and Lilly say is the single-biomarker blood test designed to test for the likelihood of amyloid pathology, a brain symptom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results